Sharif El Akhdar Appointed Chairman of Rameda Following LVP Pharma Investment
Source ↗
👁 0
💬 0
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda), one of Egypt’s leading pharmaceutical manufacturers, has announced the appointment of Sharif Ahmed El Akhdar as non-executive Chairman of its Board of Directors, representing LVP Pharma.
LVP Pharma, the investment vehicle of LimeVest, an Egypt- and Saudi-focused healthcare platform, holds an approximately 23.15% stake in Rameda. The appointment follows the completion of LVP Pharma’s strategic investment in the compa
LVP Pharma, the investment vehicle of LimeVest, an Egypt- and Saudi-focused healthcare platform, holds an approximately 23.15% stake in Rameda. The appointment follows the completion of LVP Pharma’s strategic investment in the compa
Comments (0)